Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Soluble and EV-bound CD27 act as antagonistic biomarkers in patients with solid tumors undergoing immunotherapy.
Gorgulho J, Loosen SH, Masood R, Giehren F, Pagani F, Buescher G, Kocheise L, Joerg V, Schmidt C, Schulze K, Roderburg C, Kinkel E, Fritzsche B, Wehmeyer S, Schmidt B, Kachel P, Rolling C, Götze J, Busch A, Sinn M, Pereira-Veiga T, Wikman H, Geffken M, Peine S, Matschl U, Altfeld M, Huber S, Lohse AW, Beier F, Brümmendorf TH, Bokemeyer C, Luedde T, von Felden J. Gorgulho J, et al. J Exp Clin Cancer Res. 2024 Nov 8;43(1):298. doi: 10.1186/s13046-024-03215-4. J Exp Clin Cancer Res. 2024. PMID: 39511626 Free PMC article.
Telomere Shortening in Peripheral Leukocytes Is Associated With Poor Survival in Cancer Patients Treated With Immune Checkpoint Inhibitor Therapy.
Rolles B, Gorgulho J, Tometten M, Roderburg C, Vieri M, Abels A, Vucur M, Heymann F, Tacke F, Brümmendorf TH, Luedde T, Beier F, Loosen SH. Rolles B, et al. Among authors: gorgulho j. Front Oncol. 2021 Aug 19;11:729207. doi: 10.3389/fonc.2021.729207. eCollection 2021. Front Oncol. 2021. PMID: 34490122 Free PMC article.
Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor Therapy.
Loosen SH, Gorgulho J, Jördens MS, Schulze-Hagen M, Beier F, Vucur M, Schneider AT, Koppe C, Mertens A, Kather JN, Tacke F, Keitel V, Brümmendorf TH, Roderburg C, Luedde T. Loosen SH, et al. Among authors: gorgulho j. Front Oncol. 2021 Apr 1;11:646883. doi: 10.3389/fonc.2021.646883. eCollection 2021. Front Oncol. 2021. PMID: 33869041 Free PMC article.
Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignancies.
Wirtz TH, Loosen SH, Schulze-Hagen M, Gorgulho J, Kandler J, Joerdens M, Demir M, Mohr R, Bruners P, Kuhl C, Trautwein C, Berres ML, Tacke F, Luedde T, Roderburg C. Wirtz TH, et al. Among authors: gorgulho j. Clin Transl Sci. 2021 Sep;14(5):1853-1863. doi: 10.1111/cts.13033. Epub 2021 Jul 19. Clin Transl Sci. 2021. PMID: 33787014 Free PMC article.
Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies: An exploratory analysis.
Loosen SH, Schulze-Hagen M, Vucur M, Gorgulho J, Paffenholz P, Benz F, Mohr R, Demir M, Wree A, Kuhl C, Trautwein C, Tacke F, Bruners P, Luedde T, Roderburg C. Loosen SH, et al. Among authors: gorgulho j. JGH Open. 2021 Feb 1;5(3):356-363. doi: 10.1002/jgh3.12501. eCollection 2021 Mar. JGH Open. 2021. PMID: 33732882 Free PMC article.
11 results